Principal component analysis (PCA) of the SERS spectra revealed clear clustering according to HER2 status, underscoring the platform’s diagnostic accuracy and translational potential for liquid biopsy-based cancer diagnostics. The gene discussed is ERBB2; the disease is cancer.